Zakrzewski Joseph S 4
4 · AN2 Therapeutics, Inc. · Filed Nov 27, 2024
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Purchase
Common Stock
2024-11-27$1.40/sh+2,000$2,800→ 125,199 total
Holdings
- 405,880(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.